01.05.2001 | Original Article
The new antirheumatic drug KE-298 suppresses monocyte chemoattractant protein (MCP)-1 and RANTES production in rats with adjuvant-induced arthritis and in IL-1β-stimulated synoviocytes of patients with rheumatoid arthritis
Erschienen in: Rheumatology International | Ausgabe 4/2001
Einloggen, um Zugang zu erhalten